179 related articles for article (PubMed ID: 28507102)
1. The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma.
Kumazoe M; Takai M; Hiroi S; Takeuchi C; Kadomatsu M; Nojiri T; Onda H; Bae J; Huang Y; Takamatsu K; Yamashita S; Kangawa K; Tachibana H
J Biol Chem; 2017 Jun; 292(26):10813-10823. PubMed ID: 28507102
[TBL] [Abstract][Full Text] [Related]
2. FOXO3 is essential for CD44 expression in pancreatic cancer cells.
Kumazoe M; Takai M; Bae J; Hiroi S; Huang Y; Takamatsu K; Won Y; Yamashita M; Hidaka S; Yamashita S; Yamada S; Murata M; Tsukamoto S; Tachibana H
Oncogene; 2017 May; 36(19):2643-2654. PubMed ID: 27893718
[TBL] [Abstract][Full Text] [Related]
3. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
4. GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma.
Jo JH; Kim SA; Lee JH; Park YR; Kim C; Park SB; Jung DE; Lee HS; Chung MJ; Song SY
BMC Cancer; 2021 Nov; 21(1):1241. PubMed ID: 34794402
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract][Full Text] [Related]
6. Role of cancer stem cells in pancreatic ductal adenocarcinoma.
Sergeant G; Vankelecom H; Gremeaux L; Topal B
Nat Rev Clin Oncol; 2009 Oct; 6(10):580-6. PubMed ID: 19687789
[TBL] [Abstract][Full Text] [Related]
7. Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment.
Rausch V; Liu L; Apel A; Rettig T; Gladkich J; Labsch S; Kallifatidis G; Kaczorowski A; Groth A; Gross W; Gebhard MM; Schemmer P; Werner J; Salnikov AV; Zentgraf H; Büchler MW; Herr I
J Pathol; 2012 Jul; 227(3):325-35. PubMed ID: 22262369
[TBL] [Abstract][Full Text] [Related]
8. LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling.
Huang X; Pan L; Zuo Z; Li M; Zeng L; Li R; Ye Y; Zhang J; Wu G; Bai R; Zhuang L; Wei L; Zheng Y; Su J; Deng J; Deng S; Zhang S; Zhu S; Che X; Wang C; Wu C; Chen R; Lin D; Zheng J
Nat Commun; 2021 Jun; 12(1):3830. PubMed ID: 34158490
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells.
Lyons A; Coleman M; Riis S; Favre C; O'Flanagan CH; Zhdanov AV; Papkovsky DB; Hursting SD; O'Connor R
J Biol Chem; 2017 Oct; 292(41):16983-16998. PubMed ID: 28821609
[TBL] [Abstract][Full Text] [Related]
11. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
Pan S; Chen R; Tamura Y; Crispin DA; Lai LA; May DH; McIntosh MW; Goodlett DR; Brentnall TA
J Proteome Res; 2014 Mar; 13(3):1293-306. PubMed ID: 24471499
[TBL] [Abstract][Full Text] [Related]
12. Rapid Renal Regulation of Peroxisome Proliferator-activated Receptor γ Coactivator-1α by Extracellular Signal-Regulated Kinase 1/2 in Physiological and Pathological Conditions.
Collier JB; Whitaker RM; Eblen ST; Schnellmann RG
J Biol Chem; 2016 Dec; 291(52):26850-26859. PubMed ID: 27875304
[TBL] [Abstract][Full Text] [Related]
13. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
14. PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.
Kumazoe M; Takai M; Hiroi S; Takeuchi C; Yamanouchi M; Nojiri T; Onda H; Bae J; Huang Y; Takamatsu K; Yamashita S; Yamada S; Kangawa K; Takahashi T; Tanaka H; Tachibana H
Sci Rep; 2017 May; 7(1):1917. PubMed ID: 28507327
[TBL] [Abstract][Full Text] [Related]
15. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells.
Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV
Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912
[TBL] [Abstract][Full Text] [Related]
16. Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells.
Fabian A; Stegner S; Miarka L; Zimmermann J; Lenk L; Rahn S; Buttlar J; Viol F; Knaack H; Esser D; Schäuble S; Großmann P; Marinos G; Häsler R; Mikulits W; Saur D; Kaleta C; Schäfer H; Sebens S
Cancer Lett; 2019 Jul; 453():95-106. PubMed ID: 30930235
[TBL] [Abstract][Full Text] [Related]
17. Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.
Penchev VR; Chang YT; Begum A; Ewachiw T; Gocke C; Li J; McMillan RH; Wang Q; Anders R; Marchionni L; Maitra A; Uren A; Rasheed Z; Matsui W
Mol Cancer Res; 2019 Apr; 17(4):929-936. PubMed ID: 30655325
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
19. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
[TBL] [Abstract][Full Text] [Related]
20. A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas.
Parameswaran N; Bartel CA; Hernandez-Sanchez W; Miskimen KL; Smigiel JM; Khalil AM; Jackson MW
Sci Rep; 2019 Sep; 9(1):13396. PubMed ID: 31527715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
